OintmentOintment
Schedule H (Prescription Required)Topical Corticosteroids & Anti-ItchCode: 2055

Halobetasol Propionate Ointment 0.05%

Generic Formulation:Halobetasol Propionate Ointment 0.05% w/w
Pack Size:15gm Lemi Tube
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹28.13
Brand Estimate*
₹113
Estimated Savings:₹84.87 (75% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Halobetasol Propionate (0.05% w/w) is an ultra-high potency (Class I) fluorinated topical corticosteroid. It produces intense vasoconstriction, suppression of immune cell migration, and potent anti-inflammatory action in severe hyperkeratotic and inflammatory skin conditions. Indicated for plaque psoriasis and severe steroid-responsive dermatoses.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2055.Report inaccuracy

Usage Guidelines

Apply a thin film to the affected skin once or twice daily. Rub in gently. Maximum duration: 2 consecutive weeks; maximum weekly dose: 50 g.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Stinging, burning, erythema, dry skin. Rare/Severe: Reversible HPA axis suppression, cutaneous atrophy, striae, and secondary infection.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Ultra-high potency steroid; strictly contraindicated on face, groin, or axillae. Do not use with occlusive dressings. Taper after 2 weeks.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered dermatologist or qualified medical practitioner before initiating, altering, or substituting any topical or systemic dermatological treatment.